Combined Suprascapular and Axillary Nerve Blocks for Arthroscopic Shoulder Surgery
1 other identifier
interventional
46
1 country
1
Brief Summary
Arthroscopic shoulder surgery is associated with severe pain postoperatively. Regional nerve block adding to general anesthesia might improve the quality of postoperative analgesia. The aim of the study is to compare the subacromial local anesthetic infiltration and the suprascapular-axillary nerve blocks combination for intraoperative sevoflurane consumption, postoperative analgesia and analgesic consumption.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 4, 2017
CompletedFirst Posted
Study publicly available on registry
July 11, 2017
CompletedStudy Start
First participant enrolled
August 10, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 25, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 22, 2018
CompletedAugust 7, 2018
August 1, 2018
7 months
July 4, 2017
August 6, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Postoperative VAS scores
Ranging from 0: no pain to 10: worst pain
Through postoperative period, an avarage of 30 minutes
Secondary Outcomes (1)
sevoflurane consumption
5th, 10th,20th,30th,40th,50th minutes after induction of anesthesia
Other Outcomes (1)
Bleeding assesment
5th, 10th,20th,30th,40th,50th minutes after induction of anesthesia
Study Arms (2)
Group A
SHAM COMPARATORIn group A, the surgeon will apply 20 ml of 0.250% bupivacaine to the subacromial region at the end of the procedure
Group B
ACTIVE COMPARATORIn Group B, suprascapular (10 ml of 0.250% bupivacaine ) and axillary block (10 ml of 0.250% bupivacaine) will be performed with ultrasound and nerve stimulator guidance before induction of anesthesia
Interventions
In Group B, suprascapular (10 ml of 0.250% bupivacaine ) and axillary block (10 ml of 0.250% bupivacaine) will be performed with ultrasound and nerve stimulator guidance before induction of anesthesia
In group A, the surgeon will apply 20 ml of 0.250% bupivacaine to the subacromial region at the end of the procedure
Eligibility Criteria
You may qualify if:
- American society of anesthesia physical status (ASA) 1,2 patients
- Elective arthroscopic shoulder surgery
You may not qualify if:
- ASA 3,4 patients
- Coagulation abnormality
- Body mass index \>30
- Preexisting neurological deficit Local anesthetic allergy history Diabetes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Derya Ozkan
Ankara, 06110, Turkey (Türkiye)
Related Publications (2)
Dhir S, Sondekoppam RV, Sharma R, Ganapathy S, Athwal GS. A Comparison of Combined Suprascapular and Axillary Nerve Blocks to Interscalene Nerve Block for Analgesia in Arthroscopic Shoulder Surgery: An Equivalence Study. Reg Anesth Pain Med. 2016 Sep-Oct;41(5):564-71. doi: 10.1097/AAP.0000000000000436.
PMID: 27380105RESULTRitchie ED, Tong D, Chung F, Norris AM, Miniaci A, Vairavanathan SD. Suprascapular nerve block for postoperative pain relief in arthroscopic shoulder surgery: a new modality? Anesth Analg. 1997 Jun;84(6):1306-12. doi: 10.1097/00000539-199706000-00024.
PMID: 9174311RESULT
Study Officials
- PRINCIPAL INVESTIGATOR
Derya Ozkan
Ministry of Health Diskapi Yildirim Beyazit Training and Research Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associated professor
Study Record Dates
First Submitted
July 4, 2017
First Posted
July 11, 2017
Study Start
August 10, 2017
Primary Completion
February 25, 2018
Study Completion
March 22, 2018
Last Updated
August 7, 2018
Record last verified: 2018-08
Data Sharing
- IPD Sharing
- Will not share